{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:36:35Z","timestamp":1793878595595,"version":"4.7.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"R\u00e9gion Pays de la Loire Investissement d'Avenir","award":["ANR-11-INBS-0011"],"award-info":[{"award-number":["ANR-11-INBS-0011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0609-y","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T11:53:04Z","timestamp":1540986784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Satellite cells fail to contribute to muscle repair but are functional in Pompe disease (glycogenosis type II)"],"prefix":"10.1186","volume":"6","author":[{"given":"Lydie","family":"Lagalice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Pichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliot","family":"Gougeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Soussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Deniaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Ledevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Maurier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Ciron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Franzoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Dubreil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Rouger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3882-7735","authenticated-orcid":false,"given":"Marie-Anne","family":"Colle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"key":"609_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10545-014-9728-1","volume":"37","author":"LJ Anderson","year":"2014","unstructured":"Anderson LJ, Henley W, Wyatt KM, Nikolaou V, Waldek S, Hughes DA, Lachmann RH, Logan S (2014) Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort study. J Inherit Metab Dis 37:945\u2013952. \n                    https:\/\/doi.org\/10.1007\/s10545-014-9728-1","journal-title":"J Inherit Metab Dis"},{"key":"609_CR2","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00415-011-6293-5","volume":"259","author":"C Angelini","year":"2012","unstructured":"Angelini C, Semplicini C, Ravaglia S, Bembi B, Servidei S, Pegoraro E, Moggio M, Filosto M, Sette E, Crescimanno G, Tonin P, Parini R, Morandi L, Marrosu G, Greco G, Musumeci O, Di Iorio G, Siciliano G, Donati MA, Carubbi F, Ermani M, Mongini T, Toscano A (2012) Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol 259:952\u2013958. \n                    https:\/\/doi.org\/10.1007\/s00415-011-6293-5","journal-title":"J Neurol"},{"key":"609_CR3","doi-asserted-by":"publisher","first-page":"027","DOI":"10.1385\/MN:32:1:027","volume":"32","author":"RD Bagshaw","year":"2005","unstructured":"Bagshaw RD, Mahuran DJ, Callahan JW (2005) Lysosomal membrane proteomics and biogenesis of lysosomes. Mol Neurobiol 32:027\u2013042. \n                    https:\/\/doi.org\/10.1385\/MN:32:1:027","journal-title":"Mol Neurobiol"},{"key":"609_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0022-510X(68)90058-0","volume":"7","author":"CD Bell","year":"1968","unstructured":"Bell CD, Conen PE (1968) Histopathological changes in Duchenne muscular dystrophy. J Neurol Sci 7:529\u2013544. \n                    https:\/\/doi.org\/10.1016\/0022-510X(68)90058-0","journal-title":"J Neurol Sci"},{"key":"609_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2011.02.004","volume":"103","author":"BJ Byrne","year":"2011","unstructured":"Byrne BJ, Kishnani PS, Case LE, Merlini L, M\u00fcller-Felber W, Prasad S, van d PA (2011) Pompe disease: design, methodology, and early findings from the Pompe registry. Mol Genet Metab 103:1\u201311. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2011.02.004","journal-title":"Mol Genet Metab"},{"key":"609_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.nmd.2011.06.748","volume":"21","author":"R-Y Carlier","year":"2011","unstructured":"Carlier R-Y, Laforet P, Wary C, Mompoint D, Laloui K, Pellegrini N, Annane D, Carlier PG, Orlikowski D (2011) Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: involvement patterns. Neuromuscul Disord 21:791\u2013799. \n                    https:\/\/doi.org\/10.1016\/j.nmd.2011.06.748","journal-title":"Neuromuscul Disord"},{"key":"609_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2012.159","volume":"3","author":"C De Palma","year":"2012","unstructured":"De Palma C, Morisi F, Cheli S, Pambianco S, Cappello V, Vezzoli M, Rovere-Querini P, Moggio M, Ripolone M, Francolini M, Sandri M, Clementi E (2012) Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death Dis 3:1\u201310. \n                    https:\/\/doi.org\/10.1038\/cddis.2012.159","journal-title":"Cell Death Dis"},{"key":"609_CR8","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1126\/science.1063518","volume":"294","author":"PB Dennis","year":"2001","unstructured":"Dennis PB, Jaeschke A, Saitoh M, Fowler B, Kozma SC, Thomas G (2001) Mammalian TOR: a homeostatic ATP sensor. Science 294:1102\u20131105. \n                    https:\/\/doi.org\/10.1126\/science.1063518","journal-title":"Science"},{"key":"609_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/hmg\/ddp535","volume":"19","author":"G Douillard-Guilloux","year":"2009","unstructured":"Douillard-Guilloux G, Raben N, Takikita S, Ferry A, Vignaud A, Guillet-Deniau I, Favier M, Thurberg BL, Roach PJ, Caillaud C, Richard E (2009) Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease. Hum Mol Genet 19:684\u2013696. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddp535","journal-title":"Hum Mol Genet"},{"key":"609_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00418-006-0176-3","volume":"126","author":"A Eriksson","year":"2006","unstructured":"Eriksson A, Lindstr\u00f6m M, Carlsson L, Thornell L-E (2006) Hypertrophic muscle fibers with fissures in power-lifters; fiber splitting or defect regeneration? Histochem Cell Biol 126:409\u2013417. \n                    https:\/\/doi.org\/10.1007\/s00418-006-0176-3","journal-title":"Histochem Cell Biol"},{"key":"609_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/hmg\/ddu476","volume":"24","author":"DJ Falk","year":"2015","unstructured":"Falk DJ, Todd AG, Lee S, Soustek MS, Elmallah MK, Fuller DD, Notterpek L, Byrne BJ (2015) Peripheral nerve and neuromuscular junction pathology in pompe disease. Hum Mol Genet 24:625\u2013636. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddu476","journal-title":"Hum Mol Genet"},{"key":"609_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2051-5960-2-2","volume":"2","author":"EJ Feeney","year":"2014","unstructured":"Feeney EJ, Austin S, Chien YH, Mandel H, Schoser B, Prater S, Hwu WL, Ralston E, Kishnani PS, Raben N (2014) The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients. Acta Neuropathol Commun 2:1\u201315. \n                    https:\/\/doi.org\/10.1186\/2051-5960-2-2","journal-title":"Acta Neuropathol Commun"},{"key":"609_CR13","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/cdd.2016.70","volume":"23","author":"E Fiacco","year":"2016","unstructured":"Fiacco E, Castagnetti F, Bianconi V, Madaro L, De Bardi M, Nazio F, D \u2018amico A, Bertini E, Cecconi F, Puri P, Latella L (2016) Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles. Cell Death Differ 23:1839\u20131849. \n                    https:\/\/doi.org\/10.1038\/cdd.2016.70","journal-title":"Cell Death Differ"},{"key":"609_CR14","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/mt.2010.110","volume":"18","author":"JW Foley","year":"2010","unstructured":"Foley JW, Bercury SD, Finn P, Cheng SH, Scheule RK, Ziegler RJ (2010) Evaluation of systemic follistatin as an adjuvant to stimulate muscle repair and improve motor function in Pompe mice. Mol Ther 18:1584\u20131591. \n                    https:\/\/doi.org\/10.1038\/mt.2010.110","journal-title":"Mol Ther"},{"key":"609_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2013.00363","volume":"4","author":"ES Folker","year":"2013","unstructured":"Folker ES, Baylies MK (2013) Nuclear positioning in muscle development and disease. Front Physiol 4:1\u201310. \n                    https:\/\/doi.org\/10.3389\/fphys.2013.00363","journal-title":"Front Physiol"},{"key":"609_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ymthe.2006.08.009","volume":"14","author":"T Fukuda","year":"2006","unstructured":"Fukuda T, Ahearn M, Roberts A, Mattaliano RJ, Zaal K, Ralston E, Plotz PH, Raben N (2006a) Autophagy and Mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease. Mol Ther 14:831\u2013839. \n                    https:\/\/doi.org\/10.1016\/j.ymthe.2006.08.009","journal-title":"Mol Ther"},{"key":"609_CR17","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/ana.20807","volume":"59","author":"T Fukuda","year":"2006","unstructured":"Fukuda T, Ewan L, Bauer M, Mattaliano RJ, Zaal K, Ralston E, Plotz PH, Raben N (2006b) Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol 59:700\u2013708. \n                    https:\/\/doi.org\/10.1002\/ana.20807","journal-title":"Ann Neurol"},{"key":"609_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nature16187","volume":"529","author":"L Garc\u00eda-Prat","year":"2016","unstructured":"Garc\u00eda-Prat L, Mart\u00ednez-Vicente M, Perdiguero E, Ortet L, Rodr\u00edguez-Ubreva J, Rebollo E, Ruiz-Bonilla V, Gutarra S, Ballestar E, Serrano AL, Sandri M, Mu\u00f1oz-C\u00e1noves P (2016) Autophagy maintains stemness by preventing senescence. Nature 529:37\u201342. \n                    https:\/\/doi.org\/10.1038\/nature16187","journal-title":"Nature"},{"key":"609_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-4939-3810-0_6","volume-title":"Skeletal muscle regeneration in the mouse methods and protocols","author":"GA Garry","year":"2016","unstructured":"Garry GA, Antony ML, Garry DJ (2016) Cardiotoxin induced injury and skeletal muscle regeneration. In: Kyba M (ed) Skeletal muscle regeneration in the mouse methods and protocols. Springer S. Methods in Molecular Biology, New York, pp 61\u201371"},{"key":"609_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-15352-2","volume":"7","author":"F Gatto","year":"2017","unstructured":"Gatto F, Rossi B, Tarallo A, Polishchuk E, Polishchuk R, Carrella A, Nusco E, Alvino FG, Iacobellis F, De Leonibus E, Auricchio A, Diez-Roux G, Ballabio A, Parenti G (2017) AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe disease. Sci Rep 7:1\u201312. \n                    https:\/\/doi.org\/10.1038\/s41598-017-15352-2","journal-title":"Sci Rep"},{"key":"609_CR21","first-page":"23","volume":"45","author":"JL Griffin","year":"1984","unstructured":"Griffin JL (1984) Infantile acid maltase deficiency. Cell Pathol 45:23\u201336","journal-title":"Cell Pathol"},{"key":"609_CR22","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/nm.2247","volume":"16","author":"P Grumati","year":"2010","unstructured":"Grumati P, Coletto L, Sabatelli P, Cescon M, Angelin A, Bertaggia E, Blaauw B, Urciuolo A, Tiepolo T, Merlini L, Maraldi NM, Bernardi P, Sandri M, Bonaldo P (2010) Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. Nat Med 16:1313\u20131320. \n                    https:\/\/doi.org\/10.1038\/nm.2247","journal-title":"Nat Med"},{"key":"609_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ymgme.2007.04.018","volume":"91","author":"ML Hawes","year":"2007","unstructured":"Hawes ML, Kennedy W, O\u2019Callaghan MW, Thurberg BL (2007) Differential muscular glycogen clearance after enzyme replacement therapy in a mouse model of Pompe disease. Mol Genet Metab 91:343\u2013351","journal-title":"Mol Genet Metab"},{"key":"609_CR24","doi-asserted-by":"crossref","unstructured":"Herbst A, Pak JW, McKenzie D, Bua E, Bassiouni M, Aiken JM (2007) Accumulation of mitochondrial DNA deletion mutations in aged muscle fibers: evidence for a causal role in muscle fiber loss. J Gerontol a biol Sci med Sci 62:235\u2013245. doi: 62\/3\/235 [pii]","DOI":"10.1093\/gerona\/62.3.235"},{"key":"609_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/bj0860011","volume":"86","author":"HG Hers","year":"1963","unstructured":"Hers HG (1963) Alpha-glucosidase deficiency in generalized glycogen storage disease (Pompe\u2019s disease). Biochem J 86:11\u201316","journal-title":"Biochem J"},{"key":"609_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/mus.20482","volume":"33","author":"RP Hesselink","year":"2006","unstructured":"Hesselink RP, Schaart G, Wagenmakers AJM, Drost MR, van der Vusse GJ (2006) Age-related morphological changes in skeletal muscle cells of acid alpha-glucosidase knockout mice. Muscle Nerve 33:505\u2013513. \n                    https:\/\/doi.org\/10.1002\/mus.20482","journal-title":"Muscle Nerve"},{"key":"609_CR27","first-page":"3389","volume-title":"The metabolic and molecular bases of inherited disease","author":"R Hirschhorn","year":"2001","unstructured":"Hirschhorn R, Reuser AJJ (2001) Glycogen storage disease type II: Acid alpha-Glucosidase (Acid Maltase) Deficiency. In: NYM G-H (ed) The metabolic and molecular bases of inherited disease, pp 3389\u20133420"},{"key":"609_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-017-0464-2","volume":"5","author":"J Hordeaux","year":"2017","unstructured":"Hordeaux J, Dubreil L, Robveille C, Deniaud J, Pascal Q, Dequ\u00e9ant B, Pailloux J, Lagalice L, Ledevin M, Babarit C, Costiou P, Jamme F, Fusellier M, Mallem Y, Ciron C, Huchet C, Caillaud C, Colle M-A (2017) Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease. Acta Neuropathol Commun 5:1\u201319. \n                    https:\/\/doi.org\/10.1186\/s40478-017-0464-2","journal-title":"Acta Neuropathol Commun"},{"key":"609_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-3-26","volume":"3","author":"H Jungbluth","year":"2008","unstructured":"Jungbluth H, Wallgren-Pettersson C, Laporte J (2008) Centronuclear (myotubular) myopathy. Orphanet J Rare Dis 3:1\u201313. \n                    https:\/\/doi.org\/10.1186\/1750-1172-3-26","journal-title":"Orphanet J Rare Dis"},{"key":"609_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, Leslie N, Levine J, Spencer C, McDonald M, Li J, Dumontier J, Halberthal M, Chien YH, Hopkin R, Vijayaraghavan S, Gruskin D, Bartholomew D, Van Der Ploeg A, Clancy JP, Parini R, Morin G, Beck M, De La Gastine GS, Jokic M, Thurberg B, Richards S, Bali D, Davison M, Worden MA, Chen YT, Wraith JE (2007) Recombinant human acid \u03b1-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 68:99\u2013109. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000251268.41188.04","journal-title":"Neurology"},{"key":"609_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","volume":"8","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case L, Crowley JF, Downs S, Howell RR, Kravitz RM, Mackey J, Marsden D, Martins AM, Millington DS, Nicolino M, O\u2019Grady G, Patterson MC, Rapoport DM, Slonim A, Spencer CT, Tifft CJ, Watson MS (2006) Pompe disease diagnosis and management guideline. Genet Med 8:267\u2013288. \n                    https:\/\/doi.org\/10.1097\/01.gim.0000218152.87434.f3","journal-title":"Genet Med"},{"key":"609_CR32","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1007\/s12035-017-0763-4","volume":"55","author":"NC Lee","year":"2018","unstructured":"Lee NC, Hwu WL, Muramatsu SI, Falk DJ, Byrne BJ, Cheng CH, Shih NC, Chang KL, Tsai LK, Chien YH (2018) A neuron-specific gene therapy relieves motor deficits in Pompe disease mice. Mol Neurobiol 55:5299\u20135309. \n                    https:\/\/doi.org\/10.1007\/s12035-017-0763-4","journal-title":"Mol Neurobiol"},{"key":"609_CR33","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1242\/dev.067595","volume":"138","author":"C Lepper","year":"2011","unstructured":"Lepper C, Partridge TA, Fan C-M (2011) An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 138:3639\u20133646. \n                    https:\/\/doi.org\/10.1242\/dev.067595","journal-title":"Development"},{"key":"609_CR34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.4161\/auto.19469","volume":"8","author":"AP Lieberman","year":"2012","unstructured":"Lieberman AP, Puertollano R, Raben N, Slaugenhaupt S, Walkley SU, Ballabio A (2012) Autophagy in lysosomal storage disorders. Autophagy 8:719\u2013730. \n                    https:\/\/doi.org\/10.4161\/auto.19469","journal-title":"Autophagy"},{"key":"609_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.15252\/emmm.201606547","volume":"9","author":"J Lim","year":"2017","unstructured":"Lim J, Li L, Shirihai OS, Trudeau KM, Puertollano R, Raben N (2017) Modulation of mTOR signaling as a strategy for the treatment of Pompe disease. EMBO Mol Med 9:353\u2013370. \n                    https:\/\/doi.org\/10.15252\/emmm.201606547","journal-title":"EMBO Mol Med"},{"key":"609_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/15548627.2015.1009779","volume":"11","author":"JA Lim","year":"2015","unstructured":"Lim JA, Li L, Kakhlon O, Myerowitz R, Raben N (2015) Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease. Autophagy 11:385\u2013402. \n                    https:\/\/doi.org\/10.1080\/15548627.2015.1009779","journal-title":"Autophagy"},{"key":"609_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2014.00177","volume":"6","author":"J-A Lim","year":"2014","unstructured":"Lim J-A, Li L, Raben N (2014) Pompe disease: from pathophysiology to therapy and back again. Front Aging Neurosci 6:1\u201314. \n                    https:\/\/doi.org\/10.3389\/fnagi.2014.00177","journal-title":"Front Aging Neurosci"},{"key":"609_CR38","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1590\/S0100-879X2002000600009","volume":"35","author":"MAM Luz","year":"2002","unstructured":"Luz MAM, Marques MJ, Neto HS (2002) Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells. Braz J Med Biol Res 35:691\u2013695","journal-title":"Braz J Med Biol Res"},{"key":"609_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.nmd.2008.04.010","volume":"18","author":"MC Malicdan","year":"2008","unstructured":"Malicdan MC, Noguchi S, Nonaka I, Saftig P, Nishino I (2008) Lysosomal myopathies: an excessive build-up in autophagosomes is too much to handle. Neuromuscul Disord 18:521\u2013529. \n                    https:\/\/doi.org\/10.1016\/j.nmd.2008.04.010","journal-title":"Neuromuscul Disord"},{"key":"609_CR40","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cmet.2009.10.008","volume":"10","author":"E Masiero","year":"2009","unstructured":"Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, Metzger D, Reggiani C, Schiaffino S, Sandri M (2009) Autophagy is required to maintain muscle mass. Cell Metab 10:507\u2013515. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2009.10.008","journal-title":"Cell Metab"},{"key":"609_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.9.2.493","volume":"9","author":"A Mauro","year":"1961","unstructured":"Mauro A (1961) Satellite cell of skeletal muscle fibers. J Cell Biol 9:493\u2013495. \n                    https:\/\/doi.org\/10.1083\/jcb.9.2.493","journal-title":"J Cell Biol"},{"key":"609_CR42","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature06639","volume":"451","author":"N Mizushima","year":"2008","unstructured":"Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451:1069\u20131075. \n                    https:\/\/doi.org\/10.1038\/nature06639","journal-title":"Nature"},{"key":"609_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/05704920701829043","volume":"43","author":"Z Movasaghi","year":"2008","unstructured":"Movasaghi Z, Rehman S, Rehman IU (2008) Fourier transform infrared (FTIR) spectroscopy of biological tissues. Appl Spectrosc Rev 43:134\u2013179. \n                    https:\/\/doi.org\/10.1080\/05704920701829043","journal-title":"Appl Spectrosc Rev"},{"key":"609_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s004180100250","volume":"115","author":"Y Nakae","year":"2001","unstructured":"Nakae Y, Stoward PJ, Shono M, Matsuzaki T (2001) Most apoptotic cells in mdx diaphragm muscle contain accumulated lipofuscin. Histochem Cell Biol 115:205\u2013214. \n                    https:\/\/doi.org\/10.1007\/s004180100250","journal-title":"Histochem Cell Biol"},{"key":"609_CR45","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/cdd.2012.52","volume":"19","author":"AC Nascimbeni","year":"2012","unstructured":"Nascimbeni AC, Fanin M, Masiero E, Angelini C, Sandri M (2012) The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII). Cell Death Differ 19:1698\u20131708. \n                    https:\/\/doi.org\/10.1038\/cdd.2012.52","journal-title":"Cell Death Differ"},{"key":"609_CR46","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/nan.12214","volume":"41","author":"AC Nascimbeni","year":"2015","unstructured":"Nascimbeni AC, Fanin M, Tasca E, Angelini C, Sandri M (2015) Impaired autophagy affects acid \u03b1-glucosidase processing and enzyme replacement therapy efficacy in late-onset glycogen storage disease type II. Neuropathol Appl Neurobiol 41:672\u2013675. \n                    https:\/\/doi.org\/10.1111\/nan.12214","journal-title":"Neuropathol Appl Neurobiol"},{"key":"609_CR47","doi-asserted-by":"publisher","first-page":"C190","DOI":"10.1152\/ajpcell.00066.2016","volume":"311","author":"AS Nichenko","year":"2016","unstructured":"Nichenko AS, Southern WM, Atuan M, Luan J, Peissig KB, Foltz SJ, Beedle AM, Warren GL, Call JA (2016) Mitochondrial maintenance via autophagy contributes to functional skeletal muscle regeneration and remodeling. Am J Physiol - Cell Physiol 311:C190\u2013C200. \n                    https:\/\/doi.org\/10.1152\/ajpcell.00066.2016","journal-title":"Am J Physiol - Cell Physiol"},{"key":"609_CR48","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/GIM.0b013e31819d0996","volume":"11","author":"M Nicolino","year":"2009","unstructured":"Nicolino M, Byrne B, Wraith JE, Leslie N, Mandel H, Freyer DR, Arnold GL, Pivnick EK, Ottinger CJ, Robinson PH, Loo JCA, Smitka M, Jardine P, Tat\u00f2 L, Chabrol B, McCandless S, Kimura S, Mehta L, Bali D, Skrinar A, Morgan C, Rangachari L, Corzo D, Kishnani PS (2009) Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. Genet Med 11:210\u2013219. \n                    https:\/\/doi.org\/10.1097\/GIM.0b013e31819d0996","journal-title":"Genet Med"},{"key":"609_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-018-0771-0","volume":"13","author":"R Parini","year":"2018","unstructured":"Parini R, De Lorenzo P, Dardis A, Burlina A, Cassio A, Cavarzere P, Concolino D, Della Casa R, Deodato F, Donati MA, Fiumara A, Gasperini S, Menni F, Pagliardini V, Sacchini M, Spada M, Taurisano R, Valsecchi MG, Di Rocco M, Bembi B (2018) Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy. Orphanet J Rare Dis 13:1\u201312. \n                    https:\/\/doi.org\/10.1186\/s13023-018-0771-0","journal-title":"Orphanet J Rare Dis"},{"key":"609_CR50","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ajpath.2012.04.004","volume":"181","author":"M Pauly","year":"2012","unstructured":"Pauly M, Daussin F, Burelle Y, Li T, Godin R, Fauconnier J, Koechlin-Ramonatxo C, Hugon G, Lacampagne A, Coisy-Quivy M, Liang F, Hussain S, Matecki S, Petrof BJ (2012) AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. Am J Pathol 181:583\u2013592. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2012.04.004","journal-title":"Am J Pathol"},{"key":"609_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-8-90","volume":"8","author":"SN Prater","year":"2013","unstructured":"Prater SN, Patel TT, Buckley AF, Mandel H, Vlodavski E, Banugaria SG, Feeney EJ, Raben N, Kishnani PS (2013) Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy. Orphanet J Rare Dis 8:1\u201312. \n                    https:\/\/doi.org\/10.1186\/1750-1172-8-90","journal-title":"Orphanet J Rare Dis"},{"key":"609_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aam6375.Rescue","volume":"9","author":"F Puzzo","year":"2018","unstructured":"Puzzo F, Colella P, Biferi MG, Bali D, Nicole K, Vidal P, Collaud F, Simon-sola M, Charles S, Leborgne C, Meliani A, Cohen-tannoudji M, Gjata B, Sellier P, Wittenberghe L, Van VA, Boisgerault F, Barkats M, Laforet P, Kay MA, Dwight D, Ronzitti G, Mingozzi F (2018) Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid \u03b1-glucosidase. Sci Transl Med 9:1\u201327. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aam6375.Rescue","journal-title":"Sci Transl Med"},{"key":"609_CR53","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ymthe.2004.09.017","volume":"11","author":"N Raben","year":"2005","unstructured":"Raben N, Fukuda T, Gilbert AL, de Jong D, Thurberg BL, Mattaliano RJ, Meikle P, Hopwood JJ, Nagashima K, Nagaraju K, Plotz PH (2005) Replacing acid \u03b1-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. Mol Ther 11:48\u201356. \n                    https:\/\/doi.org\/10.1016\/j.ymthe.2004.09.017","journal-title":"Mol Ther"},{"key":"609_CR54","doi-asserted-by":"publisher","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","volume":"273","author":"N Raben","year":"1998","unstructured":"Raben N, Nagaraju K, Lee E, Kessler P, Byrne B, Lee L, LaMarca M, King C, Ward J, Sauer B, Plotz P (1998) Targeted disruption of the acid \u03b1-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem 273:19086\u201319092. \n                    https:\/\/doi.org\/10.1074\/jbc.273.30.19086","journal-title":"J Biol Chem"},{"key":"609_CR55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ymgme.2010.08.001","volume":"101","author":"N Raben","year":"2010","unstructured":"Raben N, Ralston E, Chien YH, Baum R, Schreiner C, Hwu WL, Zaal KJM, Plotz PH (2010) Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy. Mol Genet Metab 101:324\u2013331. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2010.08.001","journal-title":"Mol Genet Metab"},{"key":"609_CR56","first-page":"45","volume":"26","author":"N Raben","year":"2007","unstructured":"Raben N, Roberts A, Plotz P (2007a) Role of autophagy in the pathogenesis of Pompe disease. Acta Myol 26:45\u201348","journal-title":"Acta Myol"},{"key":"609_CR57","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4161\/auto.4591","volume":"3","author":"N Raben","year":"2007","unstructured":"Raben N, Takikita S, Pittis MG, Bembi B, Marie SKN, Roberts A, Page L, Kishnani PS, Schoser BGH, Chien YH, Ralston E, Nagaraju K, Plotz PH (2007b) Deconstructing pompe disease by analyzing single muscle fibers: to see a world in a grain of sand. Autophagy 3:546\u2013552. \n                    https:\/\/doi.org\/10.4161\/auto.4591","journal-title":"Autophagy"},{"key":"609_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ajmg.c.31317","volume":"160 C","author":"N Raben","year":"2012","unstructured":"Raben N, Wong A, Ralston E, Myerowitz R (2012) Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten. Am J Med Genet Part C Semin Med Genet 160 C:13\u201321. \n                    https:\/\/doi.org\/10.1002\/ajmg.c.31317","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"issue":"5","key":"609_CR59","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/nan.12414","volume":"44","author":"M. Ripolone","year":"2017","unstructured":"Ripolone M, Violano R, Ronchi D, Mondello S, Nascimbeni A, Colombo I, Fagiolari G, Bordoni A, Fortunato F, Lucchini V, Simona S, Filosto M, Musumeci O, Tonin P, Mongini T, Previtali S, Morandi L, Angelini C, Mora M, Sandri M, Sciacco M, Toscano A, Comi GP, Moggio M (2017) Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD). Neuropathol Appl Neurobiol:1\u201314. \n                    https:\/\/doi.org\/10.1111\/nan.12414","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"609_CR60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.nmd.2010.01.014","volume":"20","author":"NB Romero","year":"2010","unstructured":"Romero NB (2010) Centronuclear myopathies: a widening concept. Neuromuscul Disord 20:223\u2013228. \n                    https:\/\/doi.org\/10.1016\/j.nmd.2010.01.014","journal-title":"Neuromuscul Disord"},{"key":"609_CR61","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1242\/dev.01169","volume":"131","author":"M Rucker","year":"2004","unstructured":"Rucker M, Fraites TJ, Porvasnik S, Lewis MA, Zolotukhin I, Cloutier DA, Byrne BJ (2004) Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease. Development 131:3007\u20133019. \n                    https:\/\/doi.org\/10.1242\/dev.01169","journal-title":"Development"},{"key":"609_CR62","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1242\/dev.073601","volume":"138","author":"R Sambasivan","year":"2011","unstructured":"Sambasivan R, Yao R, Kissenpfennig A, Van Wittenberghe L, Paldi A, Gayraud-Morel B, Guenou H, Malissen B, Tajbakhsh S, Galy A (2011) Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development 138:3647\u20133656. \n                    https:\/\/doi.org\/10.1242\/dev.073601","journal-title":"Development"},{"key":"609_CR63","doi-asserted-by":"publisher","unstructured":"Schaaf GJ, van Gestel TJM, Brusse E, Verdijk RM, de Coo IFM, van Doorn PA, van der Ploeg AT, Pijnappel WWMP (2015) Lack of robust satellite cell activation and muscle regeneration during the progression of Pompe disease. Acta Neuropathol Commun 3:1\u201311. doi: \n                    https:\/\/doi.org\/10.1186\/s40478-015-0243-x","DOI":"10.1186\/s40478-015-0243-x"},{"key":"609_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2990.1976.tb00558.x","volume":"2","author":"H Schmalbruch","year":"1976","unstructured":"Schmalbruch H (1976) Muscle fibre splitting and regeneration in diseased human muscle. Neuropathol Appl Neurobiol 2:3\u201319. \n                    https:\/\/doi.org\/10.1111\/j.1365-2990.1976.tb00558.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"609_CR65","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1365-2990.2007.00839.x","volume":"33","author":"B Schoser","year":"2007","unstructured":"Schoser B, M\u00fcller-H\u00f6cker J, Horvath R, Gempel K, Pongratz D, Lochm\u00fcller H, M\u00fcller-Felber W (2007) Adult-onset glycogen storage disease type 2: Clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 33:544\u2013559. \n                    https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00839.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"609_CR66","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","volume":"264","author":"B Schoser","year":"2017","unstructured":"Schoser B, Stewart A, Kanters S, Hamed A, Jansen J, Chan K, Karamouzian M, Toscano A (2017) Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis. J Neurol 264:621\u2013630. \n                    https:\/\/doi.org\/10.1007\/s00415-016-8219-8","journal-title":"J Neurol"},{"key":"609_CR67","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/brain\/99.4.617","volume":"99","author":"MS Schwartz","year":"1976","unstructured":"Schwartz MS, Sargeant M, Swash M (1976) Longitudinal fiber splitting in neurogenic muscular disorders - its relation to the pathogenesis of \u201cmyopathic\u201d change. Brain 99:617\u2013636","journal-title":"Brain"},{"key":"609_CR68","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1042\/EBC20170055","volume":"61","author":"E Seranova","year":"2017","unstructured":"Seranova E, Connolly KJ, Zatyka M, Rosenstock TR, Barrett T, Tuxworth RI, Sarkar S (2017) Dysregulation of autophagy as a common mechanism in lysosomal storage diseases. Essays Biochem 61:733\u2013749. \n                    https:\/\/doi.org\/10.1042\/EBC20170055","journal-title":"Essays Biochem"},{"key":"609_CR69","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.5414\/CPP47042","volume":"47","author":"L Shea","year":"2009","unstructured":"Shea L, Raben N (2009) Autophagy in skeletal muscle: implications for Pompe disease. Int J Clin Pharmacol Ther 47:S42\u2013S47. \n                    https:\/\/doi.org\/10.5414\/CPP47042","journal-title":"Int J Clin Pharmacol Ther"},{"key":"609_CR70","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/NEN.0b013e3181815994","volume":"67","author":"RL Sidman","year":"2008","unstructured":"Sidman RL, Taksir T, Fidler J, Zhao M, Dodge JC, Passini MA, Raben N, Thurberg BL, Cheng SH, Shihabuddin LS (2008) Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice. J Neuropathol Exp Neurol 67:803\u2013818. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e3181815994","journal-title":"J Neuropathol Exp Neurol"},{"key":"609_CR71","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bbagen.2013.09.010","volume":"1840","author":"N Simsek Ozek","year":"2014","unstructured":"Simsek Ozek N, Bal IB, Sara Y, Onur R, Severcan F (2014) Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles. Biochim Biophys Acta 1840:406\u2013415. \n                    https:\/\/doi.org\/10.1016\/j.bbagen.2013.09.010","journal-title":"Biochim Biophys Acta"},{"key":"609_CR72","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","volume":"257","author":"S Strothotte","year":"2010","unstructured":"Strothotte S, Strigl-Pill N, Grunert B, Kornblum C, Eger K, Wessig C, Deschauer M, Breunig F, Glocker FX, Vielhaber S, Brejova A, Hilz M, Reiners K, M\u00fcller-Felber W, Mengel E, Spranger M, Schoser B (2010) Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 257:91\u201397. \n                    https:\/\/doi.org\/10.1007\/s00415-009-5275-3","journal-title":"J Neurol"},{"key":"609_CR73","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/mt.2008.133","volume":"16","author":"B Sun","year":"2008","unstructured":"Sun B, Young SP, Li P, Di C, Brown T, Salva MZ, Li S, Bird A, Yan Z, Auten R, Hauschka SD, Koeberl DD (2008) Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy. Mol Ther 16:1366\u20131371. \n                    https:\/\/doi.org\/10.1038\/mt.2008.133","journal-title":"Mol Ther"},{"key":"609_CR74","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/jnnp.40.12.1152","volume":"40","author":"M Swash","year":"1977","unstructured":"Swash M, Schwartz MS (1977) Implications of longitudinal muscle fibre splitting in neurogenic and myopathic disorders. J Neurol Neurosurg Psychiatry 40:1152\u20131159. \n                    https:\/\/doi.org\/10.1136\/jnnp.40.12.1152","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"609_CR75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2990.1978.tb00551.x","volume":"4","author":"M Swash","year":"1978","unstructured":"Swash M, Schwartz MS, Sargeant M (1978) Pathogenesis of longitudinal splitting of muscle fibres in neurogenic disorders and in polymyositis. Neuropathol Appl Neurobiol 4:99\u2013115","journal-title":"Neuropathol Appl Neurobiol"},{"key":"609_CR76","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.15252\/embj.201488278","volume":"33","author":"AH Tang","year":"2014","unstructured":"Tang AH, Rando TA (2014) Induction of autophagy supports the bioenergetic demands of quiescent muscle stem cell activation. EMBO J 33:2782\u20132797. \n                    https:\/\/doi.org\/10.15252\/embj.201488278","journal-title":"EMBO J"},{"key":"609_CR77","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/labinvest.3700484","volume":"86","author":"BL Thurberg","year":"2006","unstructured":"Thurberg BL, Maloney CL, Vaccaro C, Afonso K, Tsai ACH, Bossen EH, Kishnani PS, O\u2019Callaghan M (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Investig 86:1208\u20131220. \n                    https:\/\/doi.org\/10.1038\/labinvest.3700484","journal-title":"Lab Investig"},{"key":"609_CR78","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","volume":"260","author":"A Toscano","year":"2013","unstructured":"Toscano A, Schoser B (2013) Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 260:951\u2013959. \n                    https:\/\/doi.org\/10.1007\/s00415-012-6636-x","journal-title":"J Neurol"},{"key":"609_CR79","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HM Van den Hout","year":"2003","unstructured":"Van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, Bakker HD, Loonen MC, de Klerk JB, Reuser AJ, van der Ploeg AT (2003) The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112:332\u2013340. \n                    https:\/\/doi.org\/10.1542\/peds.112.2.332","journal-title":"Pediatrics"},{"key":"609_CR80","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ymgme.2016.05.013","volume":"119","author":"A Van der Ploeg","year":"2016","unstructured":"Van der Ploeg A, Carlier PG, Carlier RY, Kissel JT, Schoser B, Wenninger S, Pestronk A, Barohn RJ, Dimachkie MM, Goker-Alpan O, Mozaffar T, Pena LDM, Simmons Z, Straub V, Guglieri M, Young P, Boentert M, Baudin PY, Wens S, Shafi R, Bjartmar C, Thurberg BL (2016) Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: the EMBASSY study. Mol Genet Metab 119:115\u2013123. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2016.05.013","journal-title":"Mol Genet Metab"},{"key":"609_CR81","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Van der Ploeg","year":"2010","unstructured":"Van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, Lange DJ, Leshner RT, Mayhew JE, Morgan C, Nozaki K, Park DJ, Pestronk A, Rosenbloom B, Skrinar A, van Capelle CI, van der Beek NA, Wasserstein M, Zivkovic SA (2010) A randomized study of Alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med 362:1396\u20131406. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0909859","journal-title":"N Engl J Med"},{"key":"609_CR82","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT Van der Ploeg","year":"2008","unstructured":"Van der Ploeg AT, Reuser AJJ (2008) Pompe\u2019s disease. Lancet 372:1342\u20131353. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(08)61555-X","journal-title":"Lancet"},{"key":"609_CR83","first-page":"293","volume":"129","author":"HS Vaughan","year":"1979","unstructured":"Vaughan HS, Goldspink G (1979) Fibre number and fibre size in a surgically overloaded muscle. J Anat 129:293\u2013303","journal-title":"J Anat"},{"key":"609_CR84","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1096\/fj.00-0320com","volume":"15","author":"J Wanagat","year":"2001","unstructured":"Wanagat J, Cao Z, Pathare P, Aiken J (2001) Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, and oxidative damage in sarcopenia. FASEB J 15:322\u2013332. \n                    https:\/\/doi.org\/10.1096\/fj.00-0320com","journal-title":"FASEB J"},{"key":"609_CR85","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbalip.2016.01.006","volume":"1861","author":"C Ward","year":"2016","unstructured":"Ward C, Martinez-Lopez N, Otten EG, Carroll B, Maetzel D, Singh R, Sarkar S, Korolchuk VI (2016) Autophagy, lipophagy and lysosomal lipid storage disorders. Biochim Biophys Acta 1861:269\u2013284. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2016.01.006","journal-title":"Biochim Biophys Acta"},{"key":"609_CR86","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1590\/0004-282X20130022","volume":"71","author":"LC Werneck","year":"2013","unstructured":"Werneck LC, Lorenzoni PJ, Kay CSK, Scola RH (2013) Muscle biopsy in Pompe disease. Arq Neuropsiquiatr 71:284\u2013289. \n                    https:\/\/doi.org\/10.1590\/0004-282X20130022","journal-title":"Arq Neuropsiquiatr"},{"key":"609_CR87","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/mus.10381","volume":"27","author":"PF Winkel","year":"2003","unstructured":"Winkel PF, Kamphoven JHJ, Van Den Hout HJMP, Severijnen LA, Van Doorn PA, Reuser AJJ, Van Der Ploeg AT (2003) Morphological changes in muscle tissue of patients with infantile Pompe\u2019S disease receiving enzyme replacement therapy. Muscle Nerve 27:743\u2013751. \n                    https:\/\/doi.org\/10.1002\/mus.10381","journal-title":"Muscle Nerve"},{"key":"609_CR88","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/mt.2009.37","volume":"17","author":"Y Zhu","year":"2009","unstructured":"Zhu Y, Jiang JL, Gumlaw NK, Zhang J, Bercury SD, Ziegler RJ, Lee K, Kudo M, Canfield WM, Edmunds T, Jiang C, Mattaliano RJ, Cheng SH (2009) Glycoengineered acid \u03b1-glucosidase with improved efficacy at correcting the metabolic aberrations and motor function deficits in a mouse model of pompe disease. Mol Ther 17:954\u2013963. \n                    https:\/\/doi.org\/10.1038\/mt.2009.37","journal-title":"Mol Ther"},{"key":"609_CR89","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1089\/hum.2008.010","volume":"19","author":"RJ Ziegler","year":"2008","unstructured":"Ziegler RJ, Bercury SD, Fidler J, Zhao MA, Foley J, Taksir TV, Ryan S, Hodges BL, Scheule RK, Shihabuddin LS, Cheng SH (2008) Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid \u03b1-glucosidase to correct the biochemical and motor function deficits of Presymptomatic and symptomatic Pompe mice. Hum Gene Ther 19:609\u2013621. \n                    https:\/\/doi.org\/10.1089\/hum.2008.010","journal-title":"Hum Gene Ther"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0609-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0609-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0609-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:09:00Z","timestamp":1572466140000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0609-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0609-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiments were carried out according to European guidelines for the care and use of experimental animals. The study was reviewed and approved by the Regional Ethics Committee (CEEA Pays de la Loire, authorization number APAFiS #1267).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"116"}}